Sheng Liu

Prof. Dr. Sheng Liu


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2026 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
WHWei Hao
Wei Hao
CSChenping Sun
Chenping Sun
CWChunyu Wu
Chunyu Wu
YSYouyang Shi
Youyang Shi
YQYuenong Qin
Yuenong Qin
SLSheng Liu
Sheng Liu
Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is an aggressive subtype. While trastuzumab plus pertuzumab significantly improves o